Home › Funds › Crestwood Advisors Group, LLC › AZN
Crestwood Advisors Group, LLC position in AZN
ASTRAZENECA PLC · Health Care
Crestwood Advisors Group, LLC reported holding 224,312 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$42.5M, representing 0.63% of its reported portfolio and ranking #41 among its reported holdings. Crestwood Advisors Group, LLC has disclosed AZN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Crestwood Advisors Group, LLC's AZN position evolved
Crestwood Advisors Group, LLC first disclosed a stake in AZN in Q4 2023 at 4,139 shares (US$279K). The position peaked in Q1 2026 at 232,867 shares, worth US$45.9M. Across 11 filings, Crestwood Advisors Group, LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 224,312 shares valued at US$42.5M — a reduction of -8,555 shares quarter over quarter.. Notable position changes include a 32% increase in Q1 2024 (shares rose 15% over the following quarter), a 7350% increase in Q1 2025 (shares fell 5% over the following quarter), a 53% trim in Q1 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 4.14K | $278.76K | New |
| Q1 2024 | 5.48K | $371.41K | Add |
| Q2 2024 | 5.96K | $464.74K | Add |
| Q3 2024 | 4.92K | $383.01K | Reduce |
| Q4 2024 | 5.80K | $380.28K | Add |
| Q1 2025 | 432.41K | $31.78M | Add |
| Q2 2025 | 475.18K | $33.21M | Add |
| Q3 2025 | 525.25K | $40.30M | Add |
| Q4 2025 | 492.29K | $45.26M | Reduce |
| Q1 2026 | 232.87K | $45.93M | Reduce |
| Q2 2026 | 224.31K | $42.53M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- Evelyn Partners Group Ltd 2.24M sh · $41.52B · Q2 2026
- Banque Cantonale Vaudoise 60.46K sh · $11.31B · Q2 2026
- INVESTOR AB 51.59M sh · $9.78B · Q2 2026
- Capital International Investors 34.58M sh · $6.49B · Q2 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Wellington Management Group 28.54M sh · $5.36B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 28.54M sh · $5.36B · Q2 2026
- Legal & General Investment Management America 25.75M sh · $4.82B · Q2 2026
- VANGUARD ASSET MANAGEMENT, Ltd 18.71M sh · $3.49B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.10M sh · $3.43B · Q2 2026
More on Crestwood Advisors Group, LLC
FAQ
How long has Crestwood Advisors Group, LLC held AZN?
Crestwood Advisors Group, LLC has disclosed AZN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is Crestwood Advisors Group, LLC's current position in AZN?
As of Q2 2026, Crestwood Advisors Group, LLC holds 224.31K shares of AZN (ASTRAZENECA PLC), valued at $42.53M, representing 0.63% of its reported portfolio and ranking #41.
Has Crestwood Advisors Group, LLC been buying or selling AZN?
In the latest 13F filing (Q2 2026), Crestwood Advisors Group, LLC reduced its position in AZN. The position peaked in Q1 2026 at 232.87K shares.
Which other funds hold AZN?
Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.